| Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy (NCT02268591) | NYU Langone Health | 2013-05-28 |
| Exercise Education for Adults With Seizure Disorders (NCT01856335) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-05-10 |
| Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs (NCT02556320) | University Hospital, Rouen | 2013-05-01 |
| Development and Clinical Application of [11C]Verapamil-PET (NCT02144792) | Seoul National University Hospital | 2013-05-01 |
| The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects (NCT01879423) | GlaxoSmithKline | 2013-04-28 |
| Concomitant High-resolution Recording of Haemodynamic and Electrical Activities of Children With Typical or Atypical Absence Seizures (NCT02819427) | Centre Hospitalier Universitaire, Amiens | 2013-04-03 |
| Supporting Treatment Adherence Regimens in Pediatric Epilepsy: The STAR Trial (NCT01851057) | Children's Hospital Medical Center, Cincinnati | 2013-04-01 |
| Copeptin in Childhood Epilepsy (NCT01884766) | University Hospital, Basel, Switzerland | 2013-04-01 |
| Dietary Therapy in Children With Refractory Epilepsy (NCT01983163) | All India Institute of Medical Sciences | 2013-04-01 |
| Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study (NCT01823159) | University Hospital of Mont-Godinne | 2013-04-01 |
| Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (NCT01713777) | University of Cincinnati | 2013-04-01 |
| An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures (NCT01607346) | GlaxoSmithKline | 2013-03-27 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures (NCT01832038) | UCB Pharma SA | 2013-03-26 |
| Modified Atkins Diet Plus KetoCal for Adult Epilepsy (NCT01834482) | Johns Hopkins University | 2013-03-01 |
| A Study of Hemodynamic Changes Using Near Infra-red Spectrometry (NIRS) in Infantile Epilepsy Spasms (NCT02899832) | Centre Hospitalier Universitaire, Amiens | 2013-02-21 |
| REMS Retigabine Study (NCT01938560) | GlaxoSmithKline | 2013-02-01 |
| Contribution of High Resolution EEG Functional Connectivity Measures to Presurgical Evaluation of Patients With Intractable Epilepsy (NCT01738516) | Rennes University Hospital | 2013-02-01 |
| Study of [11C]DPA-713 for Temporal Lobe Epilepsy (NCT01793532) | National Institute of Mental Health (NIMH) | 2013-01-31 |
| Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (NCT01660672) | University of Rochester | 2013-01-01 |
| Seizure Detection and Warning System in Epilepsy Patients (NCT02555410) | Brain Sentinel | 2013-01-01 |
| Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy (NCT01906398) | Mid-Atlantic Epilepsy and Sleep Center, LLC | 2013-01-01 |
| Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (NCT01392768) | Ache Laboratorios Farmaceuticos S.A. | 2013-01-01 |
| Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) (NCT01730170) | Stanford University | 2013-01-01 |
| Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) (NCT01733394) | University of Cincinnati | 2012-12-12 |
| Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours (NCT02021461) | Bial - Portela C S.A. | 2012-12-01 |
| Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy (NCT02268578) | NYU Langone Health | 2012-11-01 |
| Policy on Optimal Epilepsy Management (NCT01762215) | Northern California Institute of Research and Education | 2012-10-01 |
| Definition of Links Between Non-invasives Methods and Intracerebral EEG With Simultaneous Recordings. (NCT02875964) | Assistance Publique Hopitaux De Marseille | 2012-10-01 |
| Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy (NCT01728077) | UCB Pharma SA | 2012-10-01 |
| Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS (NCT01668654) | GlaxoSmithKline | 2012-09-04 |
| Trobalt™ Products Risk Survey (NCT01721213) | GlaxoSmithKline | 2012-09-01 |
| Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask (NCT01657084) | University of Aarhus | 2012-09-01 |
| A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures (NCT01710657) | UCB Pharma SA | 2012-09-01 |
| Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures (NCT01648101) | GlaxoSmithKline | 2012-08-29 |
| Study in Pediatric Subjects With Epilepsy (NCT01494584) | GlaxoSmithKline | 2012-07-25 |
| Lactic Acidosis During and After Seizures (NCT01833247) | Stanford University | 2012-07-01 |
| Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters (NCT01529034) | UCB Biopharma S.P.R.L. | 2012-07-01 |
| Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) (NCT01653262) | UCB Pharma SA | 2012-07-01 |
| Epilepsy Impact Scale (NCT01833234) | Stanford University | 2012-07-01 |
| Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy (NCT02644239) | University of Sao Paulo | 2012-06-01 |
| Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data (NCT01626599) | Cyberonics, Inc. | 2012-06-01 |
| Epilepsy Motion Sensing (NCT01850498) | MedtronicNeuro | 2012-05-01 |
| Analysis of Lateralization of Language in Epileptic Children by Near-infrared Spectroscopy (NIRS) (NCT02799108) | Centre Hospitalier Universitaire, Amiens | 2012-05-01 |
| 3-Dimensional Accelerometer Sub-Study (NCT01612689) | Cyberonics, Inc. | 2012-05-01 |
| Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (NCT01465997) | UCB BIOSCIENCES GmbH | 2012-05-01 |
| A Trial of Generic Substitution of Antiepileptic Drugs (NCT02429596) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2012-05-01 |
| WEUSKOP6166: Lamotrigine and Aseptic Meningitis (NCT01657864) | GlaxoSmithKline | 2012-05-01 |
| Lamotrigine Bioequivalence (NCT01995825) | University of Maryland, Baltimore | 2012-05-01 |
| Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects (NCT01462669) | GlaxoSmithKline | 2012-04-10 |
| STEP: Enhanced Physical Activity in Children and Youth With Epilepsy (NCT01550874) | McMaster University | 2012-04-02 |
| Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication (NCT01858870) | Instituto de Investigacion Sanitaria La Fe | 2012-04-01 |
| Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA) (NCT01532726) | Bial - Portela C S.A. | 2012-03-01 |
| Study of Human Sensory Perception (NCT01613911) | Swedish Medical Center | 2012-03-01 |
| Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures (NCT01749046) | Valexfarm | 2012-03-01 |
| Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy (NCT02011971) | Stanford University | 2012-02-01 |
| An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed (NCT01583036) | GlaxoSmithKline | 2012-01-16 |
| Validation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With Epilepsy (NCT03533374) | Sándor Beniczky | 2012-01-01 |
| Stress Management Intervention for Living With Epilepsy (SMILE) (NCT01444183) | Montefiore Medical Center | 2012-01-01 |
| A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy (NCT01501383) | Vertex Pharmaceuticals Incorporated | 2011-12-01 |
| eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (NCT01484977) | UCB Pharma | 2011-12-01 |
| An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy (NCT01506882) | UCB Japan Co. Ltd. | 2011-12-01 |
| WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide (NCT01607333) | GlaxoSmithKline | 2011-12-01 |
| Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite (NCT01480609) | GlaxoSmithKline | 2011-11-30 |
| Buspirone Therapy for Localized Epilepsy (NCT01496612) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-11-22 |
| EEG Objectification in Neuropsychiatry (NCT01476228) | Hadassah Medical Organization | 2011-11-01 |
| ECG Vector Determination (NCT01486056) | Cyberonics, Inc. | 2011-11-01 |
| Physiological and Biomechanical Data Collection Study in Epilepsy Subjects (NCT01485016) | Cyberonics, Inc. | 2011-11-01 |
| Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy (NCT01482026) | Hospices Civils de Lyon | 2011-11-01 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (NCT01431326) | Daniel Benjamin | 2011-11-01 |
| Electrohaemodynamic Activity in Epileptic Children : Combined Video-EEG and Near-infrared Spectroscopy (NIRS) Analysis (NCT02814331) | Centre Hospitalier Universitaire, Amiens | 2011-10-14 |
| Serum Profile of Inflammatory Factors, Immune and Angiogenic in Temporal Lobe Epilepsy (NCT01563627) | University Hospital, Montpellier | 2011-10-01 |
| Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy (NCT01431963) | GlaxoSmithKline | 2011-09-01 |
| Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents (NCT01431976) | GlaxoSmithKline | 2011-09-01 |
| Medication Adherence in Individuals With Epilepsy (NCT01566500) | Columbia University | 2011-09-01 |
| A Pharmacogenomic Exploration of Lacosamide Response (NCT01399528) | Royal College of Surgeons, Ireland | 2011-09-01 |
| A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode (NCT01417078) | Acorda Therapeutics | 2011-09-01 |
| Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy (NCT01450423) | Lars Bo Andersen | 2011-09-01 |
| Brain Dynamics in Different Stages of Arousal and Anesthesia (NCT01574443) | Weill Medical College of Cornell University | 2011-08-22 |
| Add on Lacosamide Versus High Dose Monotherapy (NCT01345058) | Brigham and Women's Hospital | 2011-08-01 |
| Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy (NCT01364597) | UCB Pharma SA | 2011-08-01 |
| Mindfulness-based Psychotherapy for Drug-resistant Epilepsy (NCT02060422) | Chinese University of Hong Kong | 2011-08-01 |
| Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users (NCT02362373) | Columbia University | 2011-08-01 |
| Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy (NCT01405508) | UCB Pharma | 2011-08-01 |
| The Management of Postoperative Craniotomy Pain in Pediatric Patients (NCT01576601) | Johns Hopkins University | 2011-08-01 |
| Epilepsy-Associated Stigma (NCT01374204) | University Hospital, Limoges | 2011-07-01 |
| Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy. (NCT00422422) | UCB Pharma | 2011-07-01 |
| Pharmacodynamics of Nasal and Buccal Midazolam Using EEG (NCT01316445) | Columbia University | 2011-07-01 |
| Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy (NCT01415362) | Spaulding Rehabilitation Hospital | 2011-07-01 |
| An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures (NCT01407523) | UCB Japan Co. Ltd. | 2011-07-01 |
| An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures (NCT01398956) | UCB Pharma | 2011-06-01 |
| Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (NCT01498822) | Korea UCB Co., Ltd. | 2011-06-01 |
| Pilot Study of Melatonin and Epilepsy (NCT00965575) | Children's Hospital Medical Center, Cincinnati | 2011-06-01 |
| Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy (NCT01320670) | Nova Scotia Health Authority | 2011-06-01 |
| Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy (NCT01296880) | State University of New York - Downstate Medical Center | 2011-06-01 |
| Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters (NCT01390220) | UCB Biopharma S.P.R.L. | 2011-06-01 |
| Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy (NCT01339559) | UCB BIOSCIENCES, Inc. | 2011-05-11 |
| Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy (NCT01703143) | Mayo Clinic | 2011-05-01 |
| Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China (NCT01357902) | GlaxoSmithKline | 2011-04-18 |
| Electrophysiology of Brain Activity During Electrode Implantation in Patients Treated With Deep Brain Stimulation (NCT03874611) | University Hospital, Grenoble | 2011-04-13 |
| Safety of Autologous MSC Infusion to Treat Epilepsy (NCT02497443) | Ministry of Public Health, Republic of Belarus | 2011-04-01 |